Clinical Trial Update: The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing how antacids affect the pharmacokinetics of raltegravir in HIV-infected participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Antacids (antacid)
• Raltegravir (raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infection | Phase 1 | Status: COMPLETED | Results posted: 2016-09-01